Watson Pharma (WPI) Unit Receives FDA Approval for Generic Revatio ANDA (PFE)

November 12, 2012 8:43 AM EST Send to a Friend
Watson Pharmaceuticals, Inc. (NYSE: WPI) announced that its subsidiary Watson Laboratories, Inc. has received approval from the U.S. Food and ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login